JB Chemicals & Pharmaceuticals Ltd. (IN:JBCHEPHARM)
:JBCHEPHARM
Want to see IN:JBCHEPHARM full AI Analyst Report?
Total Valuation
JB Chemicals & Pharmaceuticals Ltd. has a market cap or net worth of ₹346.86B. The enterprise value is ₹345.96B.
Market Cap₹346.86B
Enterprise Value₹345.96B
Share Statistics
JB Chemicals & Pharmaceuticals Ltd. has 160,558,700 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding160,558,700
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
JB Chemicals & Pharmaceuticals Ltd.’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 15.73%.
Return on Equity (ROE)0.17
Return on Assets (ROA)0.14
Return on Invested Capital (ROIC)15.73%
Return on Capital Employed (ROCE)0.21
Revenue Per Employee7.81M
Profits Per Employee1.34M
Employee Count5,311
Asset Turnover0.83
Inventory Turnover3.29
Valuation Ratios
The current PE Ratio of JB Chemicals & Pharmaceuticals Ltd. is 45.7. JB Chemicals & Pharmaceuticals Ltd.’s PEG ratio is 7.16.
PE Ratio45.7
PS Ratio7.82
PB Ratio7.80
Price to Fair Value7.80
Price to FCF51.69
Price to Operating Cash Flow95.30
PEG Ratio7.16
Income Statement
In the last 12 months, JB Chemicals & Pharmaceuticals Ltd. had revenue of 41.48B and earned 7.09B in profits. Earnings per share was 45.16.
Revenue41.48B
Gross Profit18.96B
Operating Income9.25B
Pretax Income9.52B
Net Income7.09B
EBITDA11.07B
Earnings Per Share (EPS)45.16
Cash Flow
In the last 12 months, operating cash flow was 3.62B and capital expenditures -466.90M, giving a free cash flow of 3.16B billion.
Operating Cash Flow3.62B
Free Cash Flow3.16B
Free Cash Flow per Share19.66
Dividends & Yields
JB Chemicals & Pharmaceuticals Ltd. pays an annual dividend of ₹7, resulting in a dividend yield of 0.86%
Dividend Per Share₹7
Dividend Yield0.86%
Payout Ratio33.16%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.44
52-Week Price Change30.67%
50-Day Moving Average2.07K
200-Day Moving Average1.85K
Relative Strength Index (RSI)59.84
Average Volume (3m)2.67K
Important Dates
JB Chemicals & Pharmaceuticals Ltd. upcoming earnings date is Aug 6, 2026, TBA (Confirmed).
Last Earnings DateMay 11, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
JB Chemicals & Pharmaceuticals Ltd. as a current ratio of 4.92, with Debt / Equity ratio of 0.09%
Current Ratio4.92
Quick Ratio3.77
Debt to Market Cap<0.01
Net Debt to EBITDA-0.13
Interest Coverage Ratio166.06
Taxes
In the past 12 months, JB Chemicals & Pharmaceuticals Ltd. has paid 2.43B in taxes.
Income Tax2.43B
Effective Tax Rate0.26
Enterprise Valuation
JB Chemicals & Pharmaceuticals Ltd. EV to EBITDA ratio is 29.16, with an EV/FCF ratio of 51.46.
EV to Sales7.78
EV to EBITDA29.16
EV to Free Cash Flow51.46
EV to Operating Cash Flow45.44
Balance Sheet
JB Chemicals & Pharmaceuticals Ltd. has ₹9.01B in cash and marketable securities with ₹409.10M in debt, giving a net cash position of ₹8.60B billion.
Cash & Marketable Securities₹9.01B
Total Debt₹409.10M
Net Cash₹8.60B
Net Cash Per Share₹53.59
Tangible Book Value Per Share₹182.85
Margins
Gross margin is 62.75%, with operating margin of 22.30%, and net profit margin of 17.10%.
Gross Margin62.75%
Operating Margin22.30%
Pretax Margin22.96%
Net Profit Margin17.10%
EBITDA Margin26.70%
EBIT Margin22.30%
Analyst Forecast
The average price target for JB Chemicals & Pharmaceuticals Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast5.87%
EPS Growth Forecast6.56%